ASX - By Stock
|
BOT |
Re:
Where will we be in 12 months time?
|
|
DAngel35
|
255 |
90K |
7 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
255
|
90K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Where will we be in 12 months time?
|
|
DAngel35
|
255 |
90K |
8 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
255
|
90K
|
8
|
|
ASX - By Stock
|
CTQ |
Re:
Ann: CTQ Q3-FY24 ACTIVITIES REPORT & APPENDIX 4C
|
|
DAngel35
|
11 |
2.4K |
0 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
11
|
2.4K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Commercial Day Webinar Presentation
|
|
DAngel35
|
193 |
61K |
3 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
193
|
61K
|
3
|
|
ASX - By Stock
|
CTQ |
Re:
Ann: CTQ Q3-FY24 ACTIVITIES REPORT & APPENDIX 4C
|
|
DAngel35
|
11 |
2.4K |
0 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
11
|
2.4K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Commercial Day Webinar Presentation
|
|
DAngel35
|
193 |
61K |
7 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
193
|
61K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Webinar - Registration Information
|
|
DAngel35
|
10 |
4.1K |
3 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
10
|
4.1K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
DAngel35
|
8.5K |
3.1M |
1 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
8.5K
|
3.1M
|
1
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
DAngel35
|
1 |
406 |
2 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
1
|
406
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: March 2024 Quarterly Activities Report and Appendix 4C
|
|
DAngel35
|
24 |
8.7K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
24
|
8.7K
|
1
|
|
ASX - By Stock
|
CTQ |
Re:
Ann: CTQ Q3-FY24 ACTIVITIES REPORT & APPENDIX 4C
|
|
DAngel35
|
11 |
2.4K |
3 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
11
|
2.4K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Sofdra - Post approval royalties, costs and earnings
|
|
DAngel35
|
31 |
11K |
6 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
31
|
11K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Sofdra - Post approval royalties, costs and earnings
|
|
DAngel35
|
31 |
11K |
3 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
31
|
11K
|
3
|
|
ASX - By Stock
|
FND |
Re:
$4.31 Price Target
|
|
DAngel35
|
221 |
67K |
9 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
221
|
67K
|
9
|
|
ASX - By Stock
|
CTQ |
Re:
ICR vs CTQ
|
|
DAngel35
|
3 |
872 |
0 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
3
|
872
|
0
|
|
ASX - By Stock
|
CTQ |
Re:
ICR vs CTQ
|
|
DAngel35
|
3 |
872 |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
3
|
872
|
0
|
|
ASX - By Stock
|
CTQ |
Re:
Ann: Receipt of ATO Position Paper
|
|
DAngel35
|
13 |
3.3K |
1 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
13
|
3.3K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
News: EYE Nova Eye Medical To Raise A$8M For Expansion Of Glaucoma Surgical Device Business
|
|
DAngel35
|
83 |
22K |
9 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
83
|
22K
|
9
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
DAngel35
|
2.9K |
708K |
2 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
2.9K
|
708K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
DAngel35
|
197 |
50K |
0 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
197
|
50K
|
0
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Shareholder Support and Instructions
|
|
DAngel35
|
975 |
282K |
1 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
975
|
282K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) News & Analyst Coverage
|
|
DAngel35
|
17 |
5.7K |
6 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
17
|
5.7K
|
6
|
|
ASX - By Stock
|
EYE |
Re:
Ann: USA Sales Update
|
|
DAngel35
|
53 |
12K |
1 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
53
|
12K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
DAngel35
|
2.9K |
708K |
1 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
2.9K
|
708K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
DAngel35
|
2.9K |
708K |
1 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
2.9K
|
708K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
DAngel35
|
2.9K |
708K |
0 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
2.9K
|
708K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Further Update of Proposed USA Medicare Changes
|
|
DAngel35
|
8 |
2.6K |
6 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
8
|
2.6K
|
6
|
|
ASX - By Stock
|
EYE |
Re:
Ann: AGM Presentation 23 November
|
|
DAngel35
|
25 |
6.6K |
4 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
25
|
6.6K
|
4
|
|
ASX - By Stock
|
EYE |
Re:
Ann: AGM Presentation 23 November
|
|
DAngel35
|
25 |
6.6K |
1 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
25
|
6.6K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Ann: AGM Presentation 23 November
|
|
DAngel35
|
25 |
6.6K |
3 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
25
|
6.6K
|
3
|
|
ASX - By Stock
|
EYE |
Re:
Ann: AGM Presentation 23 November
|
|
DAngel35
|
25 |
6.6K |
0 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
25
|
6.6K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
DAngel35
|
2.9K |
708K |
1 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
2.9K
|
708K
|
1
|
|
ASX - By Stock
|
EYE |
6-year efficacy data released, potential for reimbursement to remain + maintain 70%+ US sales growth???
|
|
DAngel35
|
6 |
1.6K |
21 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
6
|
1.6K
|
21
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Appendix 3Y Mr T Spurling
|
|
DAngel35
|
12 |
3.3K |
5 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
12
|
3.3K
|
5
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
DAngel35
|
2.9K |
708K |
2 |
19/11/23 |
19/11/23 |
ASX - By Stock
|
2.9K
|
708K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
DAngel35
|
2.9K |
708K |
2 |
19/11/23 |
19/11/23 |
ASX - By Stock
|
2.9K
|
708K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
2RT: A Groundbreaking Treatment for AMD (Major Partnership Deal Imminent)
|
|
DAngel35
|
81 |
23K |
3 |
19/11/23 |
19/11/23 |
ASX - By Stock
|
81
|
23K
|
3
|
|
ASX - By Stock
|
EYE |
Re:
2RT: A Groundbreaking Treatment for AMD (Major Partnership Deal Imminent)
|
|
DAngel35
|
81 |
23K |
4 |
19/11/23 |
19/11/23 |
ASX - By Stock
|
81
|
23K
|
4
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Update on Proposed USA Medicare Changes
|
|
DAngel35
|
49 |
11K |
2 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
49
|
11K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Update on Proposed USA Medicare Changes
|
|
DAngel35
|
49 |
11K |
1 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
49
|
11K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Update on Proposed USA Medicare Changes
|
|
DAngel35
|
49 |
11K |
10 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
49
|
11K
|
10
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Update on Proposed USA Medicare Changes
|
|
DAngel35
|
49 |
11K |
14 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
49
|
11K
|
14
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Update on Proposed USA Medicare Changes
|
|
DAngel35
|
49 |
11K |
0 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
49
|
11K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
DAngel35
|
2.9K |
708K |
0 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
2.9K
|
708K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
DAngel35
|
2.9K |
708K |
3 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
2.9K
|
708K
|
3
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Trading Halt
|
|
DAngel35
|
34 |
7.9K |
5 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
34
|
7.9K
|
5
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Trading Halt
|
|
DAngel35
|
34 |
7.9K |
8 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
34
|
7.9K
|
8
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Trading Halt
|
|
DAngel35
|
34 |
7.9K |
0 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
34
|
7.9K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Trading Halt
|
|
DAngel35
|
34 |
7.9K |
0 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
34
|
7.9K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Chart Thread
|
|
DAngel35
|
205 |
61K |
1 |
04/11/23 |
04/11/23 |
ASX - By Stock
|
205
|
61K
|
1
|
|